Analysts Set Array Biopharma Inc (NASDAQ:ARRY) Target Price at $6.50

Analysts Set Array Biopharma Inc (NASDAQ:ARRY) Target Price at $6.50


Shares of Array Biopharma Inc have been assigned an average recommendation of "Buy" from the seven ratings firms that are currently covering the stock. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating on the company.



from Biotech News